Osaic Holdings
AXSM icon

Osaic Holdings’s Axsome Therapeutics AXSM Stock Holding History

Osaic Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$924K Sell
5,468
-12,174
-69% -$2.1M ﹤0.01% 2785
2025
Q4 		$3.22M Buy
17,642
+11,238
+175% +$1.57M ﹤0.01% 1708
2025
Q3 		$774K Buy
6,404
+3,189
+99% +$359K ﹤0.01% 3035
2025
Q2 		$336K Buy
3,215
+1,856
+137% +$197K ﹤0.01% 3491
2025
Q1 		$158K Sell
1,359
-1,151
-46% -$131K ﹤0.01% 3830
2024
Q4 		$141K Buy
2,510
+875
+54% +$80.5K ﹤0.01% 3914
2024
Q3 		$147K Sell
1,635
-887
-35% -$77.4K ﹤0.01% 3908
2024
Q2 		$203K Sell
2,522
-284
-10% -$21K ﹤0.01% 3546
2024
Q1 		$224K Sell
2,806
-1,683
-37% -$141K ﹤0.01% 3587
2023
Q4 		$357K Sell
4,489
-700
-13% -$46.8K ﹤0.01% 3447
2023
Q3 		$363K Sell
5,189
-713
-12% -$53.3K ﹤0.01% 3521
2023
Q2 		$424K Sell
5,902
-1,002
-15% -$73.9K ﹤0.01% 3284
2023
Q1 		$426K Buy
6,904
+1,808
+35% +$119K ﹤0.01% 3238
2022
Q4 		$393K Sell
5,096
-1,020
-17% -$61K ﹤0.01% 3240
2022
Q3 		$272K Buy
6,116
+995
+19% +$49.7K ﹤0.01% 3466
2022
Q2 		$197K Sell
5,121
-332
-6% -$10.5K ﹤0.01% 3813
2022
Q1 		$237K Sell
5,453
-277
-5% -$8.59K ﹤0.01% 3884
2021
Q4 		$217K Sell
5,730
-171
-3% -$6.29K ﹤0.01% 3861
2021
Q3 		$195K Buy
5,901
+1,754
+42% +$68.4K ﹤0.01% 3925
2021
Q2 		$279K Buy
4,147
+819
+25% +$49.1K ﹤0.01% 3583
2021
Q1 		$189K Buy
3,328
+1,585
+91% +$111K ﹤0.01% 3784
2020
Q4 		$142K Sell
1,743
-126
-7% -$9.42K ﹤0.01% 3773
2020
Q3 		$133K Sell
1,869
-800
-30% -$62.3K ﹤0.01% 3592
2020
Q2 		$219K Sell
2,669
-2,090
-44% -$161K ﹤0.01% 3054
2020
Q1 		$280K Buy
+4,759
New +$388K ﹤0.01% 2583

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osaic Holdings's AXSM Position: Q1 2026 in Review

Osaic Holdings reduced its Axsome Therapeutics (AXSM) stake by 69% in Q1 2026, selling an estimated $2.1M and leaving 5,468 shares worth $924K. The position accounts for ﹤0.01% of the portfolio, ranked #2785.

Osaic Holdings first reported a position in AXSM in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.22M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Osaic Holdings held 5,468 shares of Axsome Therapeutics worth $924K as of Q1 2026.
  • Osaic Holdings sold 12,174 Axsome Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Axsome Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #2785 holding.
  • Osaic Holdings first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Axsome Therapeutics position peaked at $3.22M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.